GlaxoSmithKline's Hib vaccine obtains FDA approval

08/20/2009 | Philadelphia Inquirer, The

GlaxoSmithKline gained accelerated FDA clearance for Hiberix, a vaccine against Haemophilus influenzae Type B, which causes diseases such as meningitis and pneumonia. The approval allows the drug to be used as a booster in children 15 months to 4 years old and is part of an effort to address a shortage of Merck & Co.'s PedvaxHIB.

View Full Article in:

Philadelphia Inquirer, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President - Government Products
Health Alliance Plan
Detroit, MI
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Actuary
Meridian Health Plan
Detroit, MI
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
President/Chief Executive Officer
MedCost
Winston-Salem, NC